Compare, Analyse Jubilant Pharmova with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    MYLAN
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
MYLAN
Dec-18
JUBILANT PHARMOVA /
MYLAN
5-Yr Chart
Click to enlarge
High Rs7273,544-   
Low Rs2301,951-   
Sales per share (Unadj.) Rs574.71,630.7-  
Earnings per share (Unadj.) Rs56.444.3-  
Cash flow per share (Unadj.) Rs85.4349.6-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.81,764.1-  
Shares outstanding (eoy) m159.28514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.7 49.4%   
Avg P/E ratio x8.562.0 13.7%  
P/CF ratio (eoy) x5.67.9 71.3%  
Price / Book Value ratio x1.41.6 87.3%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,2201,413,437 5.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m21,2770-   
Avg. sales/employee Rs ThNM23,970.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM650.9-  
INCOME DATA
Net Sales Rs m91,544838,977 10.9%  
Other income Rs m4740-   
Total revenues Rs m92,018838,977 11.0%   
Gross profit Rs m19,124217,096 8.8%  
Depreciation Rs m4,619157,090 2.9%   
Interest Rs m2,87440,352 7.1%   
Profit before tax Rs m12,10519,655 61.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123-3,127 -99.9%   
Profit after tax Rs m8,98222,782 39.4%  
Gross profit margin %20.925.9 80.7%  
Effective tax rate %25.8-15.9 -162.2%   
Net profit margin %9.82.7 361.3%  
BALANCE SHEET DATA
Current assets Rs m50,383468,484 10.8%   
Current liabilities Rs m26,190341,577 7.7%   
Net working cap to sales %26.415.1 174.7%  
Current ratio x1.91.4 140.3%  
Inventory Days Days784 7.8%  
Debtors Days Days5293 55.3%  
Net fixed assets Rs m72,721162,748 44.7%   
Share capital Rs m159447 35.7%   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,039907,620 6.2%   
Long term debt Rs m37,397979,613 3.8%   
Total assets Rs m123,1042,434,589 5.1%  
Interest coverage x5.21.5 350.5%   
Debt to equity ratio x0.71.1 61.8%  
Sales to assets ratio x0.70.3 215.8%   
Return on assets %9.62.6 371.4%  
Return on equity %16.02.5 638.6%  
Return on capital %16.03.2 504.2%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,429174,340 8.9%  
From Investments Rs m-3,270-90,114 3.6%  
From Financial Activity Rs m-10,504-81,218 12.9%  
Net Cashflow Rs m2,2541,444 156.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.45 Rs / USD

Compare JUBILANT PHARMOVA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: CORAL LAB.  AMRUTANJAN HEALTHCARE  MARKSANS PHARMA.  BH.IMMUN&BIO  GLAND PHARMA  



Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Jul 23, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

The 3-Word Secret to Earning Incredible Returns

More Featured Videos

MARKET STATS